Rodrigo Gouveia

HalaMaterials (B): Negotiating Equity between Partners - Confidential instructions for Dr Gried

By  Horacio Falcao,  Alexandros Chatzieleftheriou,  Ritsa Panagiotou ,  Rodrigo Gouveia,  Heather Grover
Add to cart
A multi-issue one-on-one negotiation between a young entrepreneur (John Ambitchious) and a close-to-retirement CEO of a large corporation (George Gried). John and George are considering becoming partners on a venture John is setting up.

    Published 16 Dec 2015

    Reference 6187

    Topic Responsibility

    Region Global

    View case

    HalaMaterials (B): Negotiating Equity between Partners - Confidential instructions for Dr Gried

    Add to cart
    A multi-issue one-on-one negotiation between a young entrepreneur (John Ambitchious) and a close-to-retirement CEO of a large corporation (George Gried). John and George are considering becoming partners on a venture John is setting up.
      View case

      Pulmocit: Negotiating Pharmaceutical Products with the Government (A) - Mr Simone Moretti (AhaPharma) - Confidential Instructions

      By  Horacio Falcao,  Rodrigo Gouveia
      Add to cart
      This is a two-party negotiation between a pharmaceutical company and a government agency to decide if a new medication will be put on the reimbursement list. The pharmaceutical company has a valuable new product, the government has semi-monopolistic power over whether (or not) drugs are listed.

        Published 27 Jan 2014

        Reference 6033

        Topic Economics & Finance

        Industry Pharmaceuticals

        Region Global

        View case

        Pulmocit: Negotiating Pharmaceutical Products with the Government (A) - Mr Simone Moretti (AhaPharma) - Confidential Instructions

        Add to cart
        This is a two-party negotiation between a pharmaceutical company and a government agency to decide if a new medication will be put on the reimbursement list. The pharmaceutical company has a valuable new product, the government has semi-monopolistic power over whether (or not) drugs are listed.
          View case

          Pulmocit: Negotiating Pharmaceutical Products with the Government (B) - Dr Rozentale (Alpenian Government) - Confidential Instructions

          By  Horacio Falcao,  Rodrigo Gouveia
          Add to cart
          This is a two-party negotiation between a pharmaceutical company and a government agency to decide if a new medication will be put on the reimbursement list. The pharmaceutical company has a valuable new product, the government has semi-monopolistic power over whether (or not) drugs are listed.

            Published 27 Jan 2014

            Reference 6033

            Topic Economics & Finance

            Industry Pharmaceuticals

            Region Global

            View case

            Pulmocit: Negotiating Pharmaceutical Products with the Government (B) - Dr Rozentale (Alpenian Government) - Confidential Instructions

            Add to cart
            This is a two-party negotiation between a pharmaceutical company and a government agency to decide if a new medication will be put on the reimbursement list. The pharmaceutical company has a valuable new product, the government has semi-monopolistic power over whether (or not) drugs are listed.
              View case